Skip to main content
An official website of the United States government

An Educational Intervention for Improving Knowledge and Uptake of Genetic Counseling and Testing among African American Survivors of Breast, Prostate, or Colorectal Cancer

Trial Status: active

This clinical trial develops and tests a culturally adapted educational intervention for increasing knowledge about and uptake of genetic counseling and testing among African American survivors of breast, prostate, or colorectal cancer. Genetic research has improved the understanding of how cancer develops and is useful for facilitating the identification of populations at high risk for developing certain cancers. Hereditary cancer syndromes are estimated to account for 5-15% of breast, prostate, and colorectal cancers and the identification of variants in genes known to cause these cancers has enhanced efforts to improve early detection and prevention of them. However, current genomic research lacks representation of African American patients, and the current understanding of genetic risk factors may have limited applicability and benefit to African Americans. A culturally-appropriate educational intervention that provides cost-effective and easy access to genetic counseling and testing information and that addresses specific and unique barriers to uptake of genetic testing may improve knowledge and uptake of genetic counseling and testing among African American cancer survivors.

Have a question?
We're here to help

Chat with us: LiveHelp
Call us: 1-800-4-CANCER
(1-800-422-6237)

Which trials are right for you?

Use the checklist in our guide to gather the information you’ll need.